WHO ICTRP trial
The effect of clopidogrel in prevention of access graft thrombosis in upper…
IRCT2013012412256N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2013012412256N1 |
|---|---|
| Public title | The effect of clopidogrel in prevention of access graft thrombosis in upper extremity. |
| Scientific title | Evaluation the effect of Clopidogrel in prevention of access graft thrombosis in upper extrimity in patients undergoing hemodialysis in Emam Reza’s Hospital - Kermanshah,2012-2013 |
| Primary sponsor | Kermanshah Univesity of Medical sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Chronic Renal Failure -Hemodialysis. Chronic Renal Failure -Dialysis;Chronic Renal Failure -Dialysis |
| Interventions | Intervention 1: For all patients in the intervention group,administered tablet clopidogrel 75 mg daily, orally for 6 months and patients were followed during this 6 months and monitored of graft thrombosis . Intervention 2: For all patients… |
| Registration date | May 10, 2013 |
| Target size | 50 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: